Pharmaceutical companies | Euronews

English

Health news

Agency chief seeks help from pharma industry with medicines shortages

Greater transparency between regulators and manufacturers can foster a better understanding of supply chain vulnerabilities and reduce risks of drug shortages, European Medicines Agency (EMA) Executive Director Emer Cooke told Euronews in an interview.

Business

Novo Nordisk looks to expand into heart disease treatment

The Novo Nordisk deal is due to be wrapped up in the second quarter of this year. It will help to establish the maker of Wegovy and Ozempic in the cardiovascular treatment market.

Health news

Parliament calls for extended regulatory protection for pharmacos

The committee on environment and public health voted to increase the Commission’s proposal for regulatory protection for new pharmaceutical legislation by one-and-a-half years.

Health news

Parliament approach to IP rights amid health crises raises critics

An EU-wide mechanism to override IP rights to deliver live-saving medicines during crises will prove tricky to enforce if amendments proposed by MEPs are retained, intellectual property rights experts warn.

ADVERTISEMENT

Business

Novo Nordisk expands lead on Tesla on upbeat obesity drug trial

Novo Nordisk, of anti-obesity drug Wegovy fame, reveals encouraging initial trial data for new weight loss drug that could potentially overtake Wegovy.

Economy

Denmark's GDP soars thanks to growing pharma sector

Denmark's gross domestic product (GDP) grew 2% in the fourth quarter of 2023, largely bolstered by the country's expanding pharmaceutical sector.

Markets

Novo Nordisk crossroads: Can the pharma giant address the supply woes?

Novo Nordisk faces a pivotal moment as it grapples with supply issues amid soaring demand for its weight-loss drugs. Despite impressive financial gains and market dominance, the Danish pharma giant must navigate a critical decision.

The Big Question

Novartis doctor on Big Pharma’s battle against climate change

If the healthcare industry was a country, it would be the fifth largest polluter on Earth.

Business

Drugmaker Novo Nordisk reaches market value of $500 million

Demand for obesity drugs has pushed Novo Nordisk's share price to new highs.

Earth News

Pharma and cosmetics industries to pay for wastewater treatment

‘Polluter pays’ principle mandates key industries to take responsibility for spreading micropollutants.

Health news

€2.5 million drug now approved in Ireland, Belgium and the Netherlands

Libmeldy - a treatment for a rare disease costing €2.5 million - has become available in Ireland, Belgium and the Netherlands.

Health news

'I’m scared': UK patients struggle to access epilepsy medication

A national shortage of some epilepsy medications in the UK is putting patients' safety at risk.

Health news

Scientists discover first new antibiotics in over 60 years using AI

A new class of antibiotics for drug-resistant Staphylococcus aureus (MRSA) bacteria which was discovered using more transparent deep learning models.

Health news

AI could change the game for drug development

Biotech startups are using AI to speed drug discovery, revolutionising pharmaceuticals. Iktos aims to halve pre-clinical drug discovery time.

Health news

Americans turn to alternatives amid Ozempic shortage

Approved in 2017 for adults with type 2 diabetes, Ozempic has now become a blockbuster weight loss drug.

Health news

Australia has apologised to thalidomide survivors. What about Europe?

The Australian government issued formal apologies to victims of thalidomide this week. In Europe, the recognition of victims has been heterogeneous.

Business

Denmark's Novo Nordisk invests €2.1 billion in France

Danish pharmaceutical giant Novo Nordisk has announced major investment in a French production site to expand the capacity and manufacturing of its blockbuster anti-obesity drug.

France

Five hundred new jobs coming in Chartres, south of Paris

On Thursday, Danish pharmaceutical giant Novo Nordisk announced a major investment in a French production site to expand the capacity and manufacturing of a blockbuster anti-obesity drug.

Healthcare

France debates amendment on biomedicine substitution in pharmacies

An amendment is being debated on whether pharmacies can substitute approved replacements for biological medicines, but patient organisations have raised concerns.

Business

AstraZeneca announces new anti-obesity drug deal and positive profit

AstraZeneca's share price climbed on Thursday after it announced a multi-billion dollar deal with Chinese biopharmaceutical company Eccogene to produce a new anti-diabetes and obesity drug.